ClinVar Miner

Submissions for variant NM_024426.6(WT1):c.1447+1G>A

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV003225639 SCV003921842 pathogenic Frasier syndrome 2022-02-02 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. Splice variants at the intron 9 donor site are known to result in the deletion of three amino acids (the KTS domain) due to the use of an alternative splice site for a different isoform. The usual ratio of WT1 isoforms is 2(+KTS):1(-KTS), however this balance is impaired by intron 9 splice variants (PMID: 23295293, PMID: 25623218). (SP) Note: this splice junction is often annotated from c.1447 using an updated transcript version (NCBI). 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other splice variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. The intron 9 donor site is considered a hotspot, with at least six other variants previously reported as pathogenic in individuals with Frasier syndrome (MIM#136680) (ClinVar, DECIPHER, HGMD, LOVD, PMID: 25623218). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. The variant has previously been reported as pathogenic in two 46,XY phenotypic females with Frasier syndrome (MIM#136680) (PMID: 16717397, PMID: 23295293). (SP) 1102 - Strong phenotype match for this individual. (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed, by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.